Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) Homo sapiens (Human) Monoclonal antibody

PAD; PADI5; PDI4; PDI5; Peptidyl Arginine Deiminase Type V; Peptidylarginine deiminase IV

Add to Cart Distributors
Overview
Properties
  • SourceMonoclonal antibody preparation, Host Mouse
  • Ig Isotype IgG2b Kappa, Clone Number C4
  • PurificationProtein A + Protein G affinity chromatography
  • LabelNone
  • Immunogen RPF709Hu01-Recombinant Peptidyl Arginine Deiminase Type IV (PADI4)
  • Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
  • TraitsLiquid, Concentration 1mg/ml
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) Packages (Simulation)
  • Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) Packages (Simulation)
  • MAF709Hu22.jpg Western Blot; Sample: Human Saliva Primary Ab: 3µg/ml Mouse Anti-Human PADI4 Antibody Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specifity

The antibody is a mouse monoclonal antibody raised against PADI4. It has been selected for its ability to recognize PADI4 in immunohistochemical staining and western blotting.

Usage

Western blotting: 0.01-3µg/mL
Immunohistochemistry: 5-30µg/mL
Immunocytochemistry: 5-30µg/mL
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Giveaways

Citations

  • Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utilityPubmed:Pmc4229860
  • Peptidylarginine deiminase 4 concentration, but not polymorphisms, is associated with ICU mortality in septic shock patientsPubmed:30044533
  • Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgeryPubmed: 31213874
  • Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury

Recommend products